ENVA
Enova International, Inc.
$189.93
▲ +0.41%
+$0.77
NYSE · Financials · Financials
Enova International, Inc.
ENVA · NYSE · Financials · Financials
$189.93
▲ +0.41% · +$0.77 today
fundamentals79.4 /100 vs peers
strong
Revenue growth (TTM)17.5
20% above Sector 5Y avg avg · favorableSector 5Y avg: 14.6
EPS growth (TTM)46.6
160% above Sector 5Y avg avg · favorableSector 5Y avg: 17.9
EPS forecast (5Y)26.9
132% above Sector fwd avg avg · favorableSector fwd avg: 11.6
EPS next year21.3
strong pace
EPS growth (Q/Q)28.5
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| ENVAEnova International, Inc. | $4.73B | 15.4 | +17.5% | 79 |
| SCHWThe Charles Schwab Corporation | $157.69B | 18.0 | +21.2% | 84 |
| XBISPDR S&P Biotech ETF | $0 | 0.0 | — | 83 |
| NUNu Holdings Ltd. | $63.28B | 20.0 | — | 81 |
| MAMastercard Incorporated | $440.93B | 28.9 | +16.8% | 78 |
